Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!

HOWARU® Transit (Bifido)

HOWARU® Transit (Bifido)

HOWARU® Transit (Bifido)

A good helper for intestinal peristalsis that can effectively reduce constipation

Constipation is a common anorectal disorder. There are different factors behind it, such as excessively refined diet, body function degradation, unhealthy lifestyle and depression. Mild constipation is a nuisance to people’s normal life, and serious constipation can pose a big mental burden on patients. Apart from moderate exercise and dietary adjustments, scientists found that consumption of the appropriate amount of dietary supplements can also effectively reduce constipation. Probiotics have been proved in clinical studies to be a very good choice.

HOWARU® Transit (Bifido) contains bifidobacterium lactis HN019™, a probiotics strain recorded in many research papers. Many years of evidence-based studies have proved that it can effectively shorten colonic transit time, reduce or prevent constipation symptoms, and improve other bowel disorders such as bowel sound, nausea, diarrhea and bloating. HOWARU® Transit (Bifido) became the first probiotic product approved with a health claim by a European country of due to its excellent efficacy. It was also granted the health claim to maintaining gut heath in Canada, Japan, and Brazil.

HOWARU® Transit (Bifido) has been approved for health claims in multiple countries. It’s also the first probiotic product approved with a health claim by a European country.

100 healthy adults were enrolled in a 14-day, triple-blind and controlled experiment, to examine the impact of different doses of HOWARU® Transit (bifidobacterium lactis HN019™) on the colonic transit time of healthy adults. [1]

Results shows that compared to the placebo group, HOWARU® Transit can:

  • shorten the colonic transit time by up to 28 hours for the high-dose group and 18 hours for the low-dose group
  • significantly improve the gastrointestinal disorders of both the low-dose group and the high-dose group

Why choose HOWARU® Transit?

  • Supported by a large volume of literature indicating the positive impact on shorter colonic transit times and improvement of constipation
  • Received health claims in multiple countries
  • Proprietary stabilization techniques for patented probiotics*

1. Waller PA, et al. 2011. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol. 9: 1057-1064.